AmeriCann, Inc. (OTCPK: ACAN)
Health Care · Pharmaceuticals · US
$0.00
-50.00% today · 0.0% 1Y
AmeriCann, Inc. (OTCPK: ACAN) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $2.44K and employs 3 people.
Over the last twelve months the share price has gained 0.0%, trading between 0.00 and 0.12.
Tweenvest scores AmeriCann, Inc. across four factors: quality 29/100, value 54/100, growth 76/100. Its strongest factor is growth.
ACAN price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $2.44K
- Revenue (TTM)
- $799.18K
- P/E
- —
- EPS
- -0.10
- Dividend yield
- —
- Beta (5Y)
- 0.09
- 52-week high
- $0.12
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 24.39M
- Employees
- 3
- Next earnings
- —
About AmeriCann, Inc.
AmeriCann, Inc., with its headquarters in Denver, Colorado, functions as a specialized cannabis enterprise throughout the United States. The company offers a complete range of services to authorized cannabis businesses, handling the conception, construction, leasing, and daily management of facilities crucial for cultivating, processing, and manufacturing cannabis products. A significant venture for the firm is the Massachusetts Cannabis Center, an extensive development located on a 52-acre property in Freetown, southeastern Massachusetts. Furthermore, AmeriCann supplies cannabis for both medical applications and adult recreational consumption. Incorporated in 2010, the organization initially operated as Nevada Health Scan, Inc., eventually rebranding to AmeriCann, Inc. in 2014.
- ISIN
- US0305881072
- Founded
- 2010
- Listed since
- Jul 10, 2014
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,256.11 | +0.06% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $271.93 | +0.63% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.78 | +0.15% |
| Roche Holding AGSWX: ROP | $373.91B | CHF370.40 | -1.38% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £121.10 | -1.06% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.14 | +0.25% |
Figures last refreshed Aug 18, 2026.